中药基金LOF(501011)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-151,727,517.63 |
-46,103,697.78 |
-39,141,849.00 |
-57,405,359.36 |
| 利息合计 |
73,825.93 |
160,981.24 |
95,699.38 |
271,356.16 |
| 其中:存款利息收入 |
73,825.93 |
160,981.24 |
95,699.38 |
271,356.16 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-17,597,536.03 |
-37,148,568.17 |
-24,172,133.24 |
-53,962,889.63 |
| 其中:股票投资收益 |
-60,686.45 |
100,734.15 |
-31,993.68 |
1,298,304.37 |
| 基金投资收益 |
-17,681,743.99 |
-37,531,825.34 |
-24,209,693.26 |
-55,257,375.51 |
| 债券投资收益 |
144,894.41 |
282,523.02 |
69,553.70 |
-3,638.89 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
- |
- |
- |
-179.60 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-134,441,733.30 |
-10,141,084.79 |
-15,368,169.91 |
-4,985,276.01 |
| 其他收入 |
237,925.77 |
1,024,973.94 |
302,754.77 |
1,271,450.12 |
| 费用 |
1,151,828.19 |
2,371,849.29 |
1,144,778.51 |
2,668,305.24 |
| 管理人报酬 |
203,162.47 |
444,065.13 |
218,976.00 |
504,963.01 |
| 基金托管费 |
27,088.36 |
59,208.65 |
29,196.77 |
67,328.37 |
| 销售服务费 |
828,726.95 |
1,680,067.88 |
802,899.88 |
1,906,734.50 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
92,850.41 |
188,507.63 |
93,705.86 |
189,279.36 |
| 利润总额 |
-152,879,345.82 |
-48,475,547.07 |
-40,286,627.51 |
-60,073,664.60 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年